Contribution of redox status to hepatitis C virus E2 envelope protein function and antigenicity

被引:13
作者
Fenouillet, Emmanuel [1 ]
Lavillette, Dimitri [2 ,3 ]
Loureiro, Silvia [4 ]
Krashias, George [4 ]
Maurin, Guillemette [3 ]
Cosset, Francois-Loic [3 ]
Jones, Ian M. [4 ]
Barbouche, Rym [1 ]
机构
[1] Univ Aix Marseille 2, CNRS, UMR 6184, F-13015 Marseille, France
[2] Univ Lyon, F-69000 Lyon, France
[3] Univ Lyon 1, IFR128, INSERM, Ecole Normale Super Lyon,U758, F-69007 Lyon, France
[4] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England
基金
英国惠康基金;
关键词
D O I
10.1074/jbc.M805221200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Disulfide bonding contributes to the function and antigenicity of many viral envelope glycoproteins. We assessed here its significance for the hepatitis C virus E2 envelope protein and a counterpart deleted for hypervariable region-1 (HVR1). All 18 cysteine residues of the antigens were involved in disulfides. Chemical reduction of up to half of these disulfides was compatible with anti-E2 monoclonal antibody reaction, CD81 receptor binding, and viral entry, whereas complete reduction abrogated these properties. The addition of 5,5'-dithiobis-2-nitrobenzoic acid had no effect on viral entry. Thus, E2 function is only weakly dependent on its redox status, and cell entry does not require redox catalysts, in contrast to a number of enveloped viruses. Because E2 is a major neutralizing antibody target, we examined the effect of disulfide bonding on E2 antigenicity. We show that reduction of three disulfides, as well as deletion of HVR1, improved antibody binding for half of the patient sera tested, whereas it had no effect on the remainder. Small scale immunization of mice with reduced E2 antigens greatly improved serum reactivity with reduced forms of E2 when compared with immunization using native E2, whereas deletion of HVR1 only marginally affected the ability of the serum to bind the redox intermediates. Immunization with reduced E2 also showed an improved neutralizing antibody response, suggesting that potential epitopes are masked on the disulfide-bonded antigen and that mild reduction may increase the breadth of the antibody response. Although E2 function is surprisingly independent of its redox status, its disulfide bonds mask antigenic domains. E2 redox manipulation may contribute to improved vaccine design.
引用
收藏
页码:26340 / 26348
页数:9
相关论文
共 47 条
[1]   Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env [J].
Barbouche, R ;
Lortat-Jacob, H ;
Jones, IM ;
Fenouillet, E .
MOLECULAR PHARMACOLOGY, 2005, 67 (04) :1111-1118
[2]   Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion [J].
Barbouche, R ;
Miquelis, R ;
Jones, IM ;
Fenouillet, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :3131-3136
[3]   Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction [J].
Barth, Heidi ;
Schnober, Eva K. ;
Zhang, Fuming ;
Linhardt, Robert J. ;
Depla, Erik ;
Boson, Bertrand ;
Cosset, Francois-Loic ;
Patel, Arvind H. ;
Blum, Hubert E. ;
Baumert, Thomas F. .
JOURNAL OF VIROLOGY, 2006, 80 (21) :10579-10590
[4]   Cell entry of hepatitis C virus [J].
Bartosch, B ;
Cosset, FL .
VIROLOGY, 2006, 348 (01) :1-12
[5]   An interplay between hypervariable region 1 of the Hepatitis C Virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies [J].
Bartosch, B ;
Verney, G ;
Dreux, M ;
Donot, P ;
Morice, Y ;
Penin, F ;
Pawlotsky, JM ;
Lavillette, D ;
Cosset, FL .
JOURNAL OF VIROLOGY, 2005, 79 (13) :8217-8229
[6]   Oxidative protein folding: An update [J].
Benham, AM .
ANTIOXIDANTS & REDOX SIGNALING, 2005, 7 (5-6) :835-838
[7]   DISULFIDE BONDS AND THE STABILITY OF GLOBULAR-PROTEINS [J].
BETZ, SF .
PROTEIN SCIENCE, 1993, 2 (10) :1551-1558
[8]   Hepatitis C virus glycoprotein E2 binding to CD81: The role of E1E2 cleavage and protein glycosylation in bioactivity [J].
Chan-Fook, C ;
Jiang, WR ;
Clarke, BE ;
Zitzmann, N ;
Maidens, C ;
McKeating, JA ;
Jones, IM .
VIROLOGY, 2000, 273 (01) :60-66
[9]   Immunogenicity of the outer domain of a HIV-1 clade C gp120 [J].
Chen, Hongying ;
Xu, Xiaodong ;
Jones, Ian M. .
RETROVIROLOGY, 2007, 4 (1)
[10]   How does hepatitis C virus enter cells? [J].
Diedrich, Gundo .
FEBS JOURNAL, 2006, 273 (17) :3871-3885